CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Kozono, MD
Alliance Foundation Trials, LLC.
Study Director - James Urbanic, MD
University of California, San Diego
Study Chair - Jyoti Patel, MD
University of Chicago
Study Chair - Linda Martin, MD, MPH
University of Virginia
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Northwestern University
Chicago, Illinois, United States
- University of Chicago Medical Center
Chicago, Illinois, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Lowell General Hospital
Lowell, Massachusetts, United States
- Suny Upstate Medical University
Syracuse, New York, United States
- Baptist Cancer Center
Memphis, Tennessee, United States
- University of Texas Md Anderson Cancer Center
Houston, Texas, United States
- University of Virginia Health System
Charlottesville, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Mar 2021
- Primary completion
- 31 Jul 2026
- Completion
- 31 Jul 2026
- Last update posted
- 8 Jul 2025
- Registered enrollment
- 38
- Registry id
- NCT04062708
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.